Evidence map›Paper›PMID 38568925›Full record

ArticlePloS one2024

Comparing psychological versus pharmacological treatment in emotional disorders: A network analysis.

Francisco Jurado-González, Francisco García-Torres, Alba Contreras, Roger Muñoz-Navarro, César González-Blanch, Leonardo Adrián Medrano, Paloma Ruiz-Rodríguez, Eliana M Moreno, Carolina Pérez-Dueñas, Antonio Cano-Vindel and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Francisco Jurado-GonzálezDepartment of Psychology, University of Cordoba/Maimonides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofia University Hospital, Cordoba, Spain.ORCID 0000-0003-3619-142X
Francisco García-TorresDepartment of Psychology, University of Cordoba/Maimonides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofia University Hospital, Cordoba, Spain.
Alba ContrerasUniversity Catholique San Antonio of Murcia, Murcia, Spain.
Roger Muñoz-NavarroDepartment of Psychology and Sociology, Faculty of Social and Human Sciences, University of Zaragoza, Teruel, Spain.
César González-BlanchMental Health Centre, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Cantabria, Spain.
Leonardo Adrián MedranoFaculty of Psychology, Siglo 21 University, De los Latinos, Cordoba, Argentina.
Paloma Ruiz-RodríguezCastilla La Nueva Primary Care Centre, Health Service of Madrid, Fuenlabrada, Madrid, Spain.ORCID 0000-0001-8140-0767
Eliana M MorenoDepartment of Psychology, University of Cordoba/Maimonides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofia University Hospital, Cordoba, Spain.ORCID 0000-0003-3467-5316
Carolina Pérez-DueñasDepartment of Psychology, University of Cordoba/Maimonides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofia University Hospital, Cordoba, Spain.ORCID 0000-0002-9991-2733
Antonio Cano-VindelFaculty of Psychology, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0002-5449-5454
Juan A MorianaDepartment of Psychology, University of Cordoba/Maimonides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofia University Hospital, Cordoba, Spain.
Instituto Maimónides de Investigación Biomédica de Córdoba · ESMadrid Health Service · ESUniversidad Católica de Murcia · ESUniversidad Complutense de Madrid · ESUniversidad de Cantabria · ESUniversidad de Zaragoza · ESUniversidad Siglo 21 · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transdiagnostic group cognitive behavioural therapy (TD-GCBT) is more effective in improving symptoms and severity of emotional disorders (EDs) than treatment as usual (TAU; usually pharmacological treatment). However, there is little research that has examined the effects of these treatments on specific symptoms. This study used Network Intervention Analysis (NIA) to investigate the direct and differential effects of TD-GCBT + TAU and TAU on specific symptoms of anxiety and depression. Data are from a multicentre randomised clinical trial (N = 1061) comparing TD-GCBT + TAU versus TAU alone for EDs. The networks included items from the PHQ-9 (depression) and GAD-7 (anxiety) questionnaire and mixed graphical models were estimated at pre-treatment, post-treatment and 3-, 6- and 12-month follow-up. Results revealed that TD-GCBT + TAU was associated with direct effects, mainly on several anxiety symptoms and depressed mood after treatment. New direct effects on other depressive symptoms emerged during the follow-up period promoted by TD-GCBT compared to TAU. Our results suggest that the improvement of anxiety symptoms after treatment might precipitate a wave of changes that favour a decrease in depressive symptomatology. NIA is a methodology that can provide fine-grained insight into the likely pathways through which treatments exert their effects.

Indexed as

Cognitive Behavioral TherapyAnxietyAnxiety DisordersDepressionHumansMood DisordersMulticenter Studies as TopicRandomized Controlled Trials as TopicTreatment Outcome

Identifiers

PMID38568925
PMCPMC10990220
OpenAlexW4393853678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.